Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine

Leukemia. 2011 Jul;25(7):1207-9. doi: 10.1038/leu.2011.63. Epub 2011 Apr 5.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Antimetabolites / therapeutic use*
  • Azacitidine / therapeutic use*
  • Chromosome Deletion
  • Chromosomes, Human, Pair 5 / genetics*
  • Chromosomes, Human, Pair 7 / genetics*
  • Compassionate Use Trials
  • Follow-Up Studies
  • Humans
  • In Situ Hybridization, Fluorescence
  • Kaplan-Meier Estimate
  • Karyotyping
  • Monosomy*
  • Myelodysplastic Syndromes / drug therapy
  • Myelodysplastic Syndromes / genetics*
  • Myelodysplastic Syndromes / mortality
  • Prognosis
  • Proportional Hazards Models
  • Treatment Outcome

Substances

  • Antimetabolites
  • Azacitidine

Supplementary concepts

  • Chromosome 7, monosomy